ArticleRSC advances2025
Synthesis, characterization, and anti-cancer activity evaluation of Ba-doped CuS nanostructures synthesized by the co-precipitation method.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- ZnS-CuS-CuRSC advances · 2026Article
- Advances in Versatile Copper Sulfide-Based Nanoplatforms: From Synthesis and Properties to Multifaceted Biomedical Applications.International journal of nanomedicine · 2026Review
- Copper sulfide nanoparticles application under field condition increases Eruca sativa morpho-physiological response, yield, and biodiesel production for sustainable energy.Scientific reports · 2025Article
- Effect of cobalt doping on the physicochemical and photocatalytic properties of CuRSC advances · 2025Article
- Synthesis, characterization, and photocatalytic study of Bi-doped CuS nanoparticles.RSC advances · 2025Article
- Tailoring CdO-CuO-ZnO Mixed Metal Oxide Nanocomposites for Anticancer Activity via Co-Precipitation Method.Nanotechnology, science and applications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pure and barium (Ba)-doped copper sulfide nanostructures were synthesized by the chemical co-precipitation method at room temperature. The pure and Ba-doped CuS nanoparticles have been compared structurally, morphologically, and optically using X-ray diffraction (XRD), transmission electron microscopy (TEM), total reflection X-ray fluorescence (TXRF), diffuse reflectance spectroscopy (DRS) and photoluminescence (PL) spectroscopy. The results of X-ray diffraction (XRD) showed that the CuS nanostructures have a hexagonal structure with crystallite sizes ranging from 15.14 to 16.69 nm. TXRF was used to confirm the presence of Ba-doped CuS. Diffuse reflectance spectroscopy (DRS) analysis revealed that the bandgap energy of the CuS nanostructures increased with increasing Ba doping concentration (1.38 to 1.82 eV). Optical constants such as absorption coefficient, extinction coefficient, and refractive index were calculated. A photoluminescence study of CuS was carried out. One photoluminescence (PL) band was found at 826 nm (1.5 eV) at room temperature and was attributed to band-to-band (BB) and band-to-impurity recombination. The MTT assay was used to measure the cytotoxicity effect on human lung cancer cell lines (A549). The results showed that CuS nanostructure with 5% Ba doping exhibits more toxicity than other samples, with an IC
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.